The Latin America, Middle East and Africa Metagenomics Market would witness market growth of 17.2% CAGR during the forecast period (2022-2028).
Binding is the association of a specific sequence with an organism. In similarity-based binning, tools like BLAST are used to swiftly scan existing public datasets for phylogenetic markers or identical sequences. MEGAN has implemented this strategy. Comparative investigations of metagenomes can shed light on the function of complex bacterial communities and their involvement in maintaining host health.
At the level of sequence composition (comparing GC content or genome size), taxonomic diversity, and functional complement, pairwise or multiple comparisons of metagenomes are possible. Based on 16S rRNA and other phylogenetic marker genes, or in the case of low-diversity communities, genome reconstruction from the metagenomic dataset, population organization, and phylogenetic diversity can be compared.
It is possible to make functional comparisons between metagenomes by comparing sequences against benchmark datasets such as COG or KEGG, tabulating the abundance by category, and evaluating the statistical significance of the discrepancies. This gene-centric approach stresses the functional complementary of the community as a whole as opposed to taxonomic categories and demonstrates that functional complements are equivalent under identical environmental conditions.
As one of the most economically developed and diverse nations in the Middle East, the UAE boasts a robust healthcare system. The UAE government has prioritized the creation of world-class health systems, and as a result, the industry has evolved and increased substantially in recent years. As soon as COVID-19 emerged in January 2020, the UAE government implemented preventative health measures. Due to the leadership's hard efforts, the UAE is considered one of the finest countries in the world and the best in the Arab world in terms of COVID-19 response.
The Brazil market dominated the LAMEA Metagenomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $51.7 Million by 2028.The Argentina market is experiencing a CAGR of 17.8% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 16.8% during (2022 - 2028).
Based on Workflow, the market is segmented into Sequencing, Pre-sequencing and Data Analysis. Based on Product, the market is segmented into Kits & Reagents, Sequencing & Data Analytics Services and Software. Based on Technology, the market is segmented into Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing and Others. Based on Application, the market is segmented into Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food & Nutrition and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Metagenomics Market is Predict to reach $3.2 Billion by 2028, at a CAGR of 13.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Rad Laboratories, Inc., Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and F. Hoffmann-La Roche Ltd.
By Workflow
By Product
By Technology
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
